DocGo Inc. (DCGO) News
Track canonical SquawkNews coverage tagged to DCGO, DocGo Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 10 indexed stories across 8 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
DocGo Price Target Maintained With a $3.00/Share by Needham
Ratings actions from Benzinga
NEWS | Sep 30, 2026, 10:12 AM UTC
L
Needham reiterates Buy rating on DocGo, $3 price target
Needham reiterated their Buy rating on DocGo's stock with a price target of $3.00.The price target implies an upside of 715.2% from the Sep 29 close of $0.37.Key takeaways from the analyst noteStrategic Acquisition Enhan
MNA | Sep 30, 2026, 10:01 AM UTC
L
DocGo Announces Upcoming Webinar to Outline Vision and Details of the Pending Hicuity Health Acquisition
DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health and medical transportation services, announced today that Lee Bienstock, Chief Executive Officer, and senior Hicuity Health exec
MNA | Sep 23, 2026, 11:35 AM UTC
L
DocGo CEO Lee Bienstock to meet in 1x1 at Morgan Stanley healthcare conference
DocGo said CEO Lee Bienstock will participate in 1x1 meetings at the Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday.
EQUITY | Sep 01, 2026, 11:35 AM UTC
L
DocGo shares fall after worse Q2 results, FY2026 sales guidance narrows
DocGo reports worse-than-expected Q2 financial results and narrows its FY2026 sales guidance, prompting shares to trade lower, per Alpaca Benzinga Live.
EARNINGS | Aug 18, 2026, 02:28 PM UTC
L
DocGo reports Q2 2026 results, signs Hicuity Health deal
DocGo reported Q2 2026 revenue of $73.4 million, a year-over-year decline from $80.4 million, and said it signed a definitive agreement to acquire Hicuity Health.
EARNINGS | Aug 17, 2026, 09:51 PM UTC
L
DocGo narrows FY2026 sales guidance to $305 million-$310 million
DocGo (NASDAQ: DCGO) narrows its FY2026 sales outlook to $305.000 million-$310.000 million from $300.000 million-$315.000 million, versus a $306.281 million estimate.
EARNINGS | Aug 17, 2026, 08:23 PM UTC
L
DocGo to report narrower Q2 loss after raising FY2026 sales guidance
DocGo Inc. will release its second-quarter earnings after Monday’s close, with analysts expecting a 15-cent loss per share on $75.57 million of revenue versus a 21-cent loss and $80.42 million a year ago.
EARNINGS | Aug 14, 2026, 10:57 AM UTC
L
Did DocGo Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Did DocGo Inc. Insiders Breach their Fiduciary Duties t
EQUITY | Jul 03, 2026, 04:30 PM UTC
L
DocGo Extends Share Repurchase Program Expiration To December 31
Sec Filing
REGULATION | Jul 02, 2026, 08:23 PM UTC